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NADPH oxidaseThe endothelial nitric oxide synthase (eNOS) has been implicated in the rapid (Frank–Starling) and slow
(Anrep) cardiac response to stretch. Our work and that of others have demonstrated that a neuronal nitric
oxide synthase (nNOS) localized to the myocardium plays an important role in the regulation of cardiac
function and calcium handling. However, the effect of nNOS on the myocardial response to stretch has yet to
be investigated. Recent evidence suggests that the stretch-induced release of angiotensin II (Ang II) and
endothelin 1 (ET-1) stimulates myocardial superoxide production from NADPH oxidases which, in turn,
contributes to the Anrep effect. nNOS has also been shown to regulate the production of myocardial
superoxide, suggesting that this isoform may inﬂuence the cardiac response to stretch or ET-1 by altering the
NO-redox balance in the myocardium. Here we show that the increase in left ventricular (LV) myocyte
shortening in response to the application of ET-1 (10 nM, 5 min) did not differ between nNOS−/− mice and
their wild type littermates (nNOS+/+). Pre-incubating LV myocytes with the NADPH oxidase inhibitor,
apocynin (100 μM, 30 min), reduced cell shortening in nNOS−/− myocytes only but prevented the positive
inotropic effects of ET-1 in both groups. Superoxide production (O2−) was enhanced in nNOS−/− myocytes
compared to nNOS+/+; however, this difference was abolished by pre-incubation with apocynin. There was
no detectable increase in O2− production in ET-1 pre-treated LV myocytes. Inhibition of protein kinase C
(chelerythrine, 1 μM) did not affect cell shortening in either group, however, protein kinase A inhibitor, PKI
(2 μM), signiﬁcantly reduced the positive inotropic effects of ET-1 in both nNOS+/+ and nNOS−/−myocytes.
Taken together, our ﬁndings show that the positive inotropic effect of ET-1 in murine LV myocytes is
independent of nNOS but requires NADPH oxidases and protein kinase A (PKA)-dependent signaling. These
results may further our understanding of the signaling pathways involved in the myocardial inotropic
response to stretch.© 2009 Elsevier B.V. Open access under CC BY-NC-ND license.1. IntroductionMechanical stretch is an important physiological and pathological
stimulus in the heart. It is well established that mechanical stretch
enhances myocardial contractility [1] but the underlying mechanisms
are not completely understood. Under physiological conditions, the
myocardial response to stretch is biphasic and involves a large and
rapid (within a beat) increase in inotropy, i.e., the Frank–Starling
response, which is followed by a slower and a less pronounced
increase in the force of contraction, i.e., the Anrep effect. The rapid
increase in contraction occurs as a result of a length-dependent
increase in cross-bridge formation and myoﬁlament Ca2+ sensitivity
whereas the slow rise in force that follows is associated with an
increase in the amplitude of the intracellular Ca2+ transients [2].
Sustained mechanical stretch stimulates the release of angiotensin II
(Ang II) from the ventricular myocardium which, in turn, contributes
to the Anrep effect via a mechanism that involves the release of+44 1865 514066.
. Zhang).
-NC-ND license.endothelin 1 (ET-1) [3–5]. It has been postulated that an increase in
Ca2+ entry via the Na+–Ca2+ exchanger (NCX) following activation of
the Na+–H+ exchanger (NHE) may play an important role in
mediating the Anrep effect [3–6]. Indeed, several investigators [4–6]
have shown that in trabeculae, papillary muscles or isolated
ventricular myocytes from rat, cat or humans, inhibition of NHE
blunted the stretch-mediated increase in intracellular Na+i as well as
its positive inotropic effect. Similarly, inhibition of the reversemode of
the NCX abolished the increase in intracellular Ca2+i without affecting
the increase in intracellular Na+i [4] (Fig. 1).
Mechanical stimuli (e.g., circumferential or longitudinal stretch)
have been shown to stimulate nitric oxide (NO) release from both the
vascular endothelium and LV myocytes [7–8] with potentially
important consequences in the regulation of LV function [8,9]. In
particular, stimulation of NO production from the coronary endothe-
lium or intracoronary infusion of NO donors has been shown to hasten
LV relaxation and reduce LV end-diastolic stiffness, which in turn may
inﬂuence the Frank–Starling response by increasing LV end-diastolic
volume and the length of the myocardial muscle ﬁbers [10].
Conversely, inhibition of NO synthesis attenuates the rise in cardiac
Fig.1. Schematic illustration of themechanisms involved in the slow inotropic response to stretch in cardiacmyocytes. Sustained stretch induces the release of preformed angiotensin
II (Ang II). Cardiac AT1 receptor stimulation promotes the release of endothelin-1 (ET-1). Downstream of ET-1A receptors, activation of NADPH oxidases produces reactive oxygen
species (ROS). Redox-dependent stimulation of Na+–H+ exchanger (NHE) leads to an increase in intracellular Na+ concentration which in turn increases intracellular Ca2+ via the
reverse mode of the Na+–Ca2+ exchanger. Mechanical stretch may also directly activate the signaling pathways (e.g. myosin light chain kinase, MLCK) that mediate slow force
response to stretch of myocardium. Modiﬁed from Caldiz et al. with permission.
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hearts [9] suggesting that the stretch-mediated stimulation of
constitutive NO production in the myocardium contributes to the
ability of the heart to adjust cardiac output to meet the demand posed
by increasing LV ﬁlling pressure.
Myocardial production of NO by the endothelial nitric oxide
synthase (eNOS) has been implicated in the Anrep effect. Petroff et al.
[8] have shown that the increase in Ca2+ transient amplitude observed
in rat LV myocytes subjected to sustained longitudinal stretch whilst
embedded in agarose is associated with an increase in NO production
and is abolishedbyNOS inhibitionorby selective disruptionof the eNOS
gene [8]. The stretched myocytes exhibited an increase in Ca2+ spark
frequency in the absence of changes in sarcoplasmic reticulum (SR)
Ca2+ content. These data suggest that stretch-induced NO release
may increase contraction by increasing RyR open probability and SR
Ca2+ release. However, other investigators have shown that the slow
increase in contraction in response to stretch in rat trabeculae is
maintained even after SR Ca2+ release has been disrupted [11] and that
non-isoform speciﬁc inhibition of NOS had no impact on the positive
inotropic effect of longitudinal stretch in rat LV myocytes [12].
A neuronal isoform of NOS (nNOS) has been identiﬁed in the
mammalian myocardium [13]. In contrast with the myocardial and
vascular eNOS isoform, which is mostly localized to plasmalemmal
microdomains named caveolae, nNOS has been co-localized with RyR
Ca2+ release channels in the cardiac SR [14]. Our work [15–17] and
that of others [18–20] show that acute nNOS-speciﬁc inhibition or
targeted disruption of the nNOS gene (nNOS−/−) results in an
enhanced left ventricular (LV) contractility in vitro and in vivo, which
appears to be driven by a higher Ca2+ entry through the plasmalemma
Ca2+ current (ICa) [16]. nNOS disruption also results in severely
impaired myocardial relaxation both in vivo [17,19] and in isolated
myocytes [15,16,20]. We have shown that a reduction in the PKA-
dependent phosphorylation of phospholamban, secondary to an
increase in protein phosphatase activity, accounts for the slower
SR Ca2+-reuptake and impaired relaxation in the myocardium of
nNOS−/−mice [21]. nNOS-derived NOmay also regulate RyR function
by modulating the channel's open probability and thus the diastolic
“leak” of Ca2+ from the SR [22]. These ﬁndings suggest that changes in
the expression and activity of myocardial nNOS may regulate the
myocardial response to stretch, directly through the effect of NO on
Ca2+ handling proteins [16,21].
Emerging evidence has associated mechanical stretch with the
local formation of reactive oxygen species (ROS) in the myocardium
[23–25]. At low concentrations, ROS appear to modulate cell signalingchieﬂy by modifying key thiol groups on proteins that possess
regulatory functions [26–28]. For instance, hydrogen peroxide
transiently inhibits protein tyrosine phosphatase activity through
the reversible oxidation of catalytic cysteines [27]. A number of
studies over the last decade have indicated that NADPH oxidases are
the main source of ROS involved in myocardial redox signaling and
stretch responses [24,25]. NADPH oxidase in cardiac myocytes
comprises of a catalytic unit gp91phox (termed Nox2) that forms a
heterodimer with p22phox subunit in the membrane and cytosolic
regulatory subunits p47phox and p67phox and the small GTP-binding
protein Rac1 [29]. Stretch triggers the release of Ang II and ET-1 from
the myocardium, which in turn stimulates the activity of NOX2-
NADPH oxidases [23,25] via a protein kinase C (PKC)-mediated
phosphorylation of the oxidase's p47phox subunit, leading to its
translocation to the membrane-bound cytochrome (i.e., to the NOX2
and p22phox complex) [29]. This mechanism accounts for the increase
in superoxide production in response to Ang II in a number of
preparations [30–32]. Recent evidence has also shown that Rac1-
GTPase is rapidly activated by both stretch [33,34] and Ang II in
ventricular myocytes [35], implicating an early role of Rac1 in
mechanotransduction and neurohumoral signaling in the myocar-
dium. Taken together these data suggest that sustained stretch may
lead to Ang II-mediated p47phox phosphorylation, transcriptional
upregulation of the NADPH oxidase subunits, and activation of Rac1-
GTPase, all of which would be expected to increase local ROS-
mediated signaling (Fig. 1).
Recent evidence shows that inhibition of nNOS increases myo-
cardial superoxide production [36], suggesting that nNOS may play a
novel role in the regulation of myocardial response to stretch
indirectly through its alteration of myocardial ROS formation. In this
study, we demonstrate that increased activity of NADPH oxidase
contributes to enhanced LV myocyte contraction in nNOS−/− mice
and that PKA acts as downstream of ROS in the mechanism of
mechanical stretch regulation of myocardial contraction.
2. Materials and methods
2.1. Animals
Mice (2–5 months old) homozygous for targeted disruption of
nNOS (nNOS−/−) were compared to their age-matched wild type
littermates (nNOS+/+). All protocols were in accordance with the
Home Ofﬁce Guidance on the Operation of Animals (Scientiﬁc
Procedures) Act, 1986.
Fig. 2. Effects of ET-1 on cell shortening in LV myocytes isolated from nNOS−/− mice
and their wild type littermates (nNOS+/+). (A) Continuous recordings of ﬁeld
stimulated (3 Hz) myocyte shortening under control conditions (Ctr) and during the
application of 10 nM endothelin 1 (ET-1) and representative individual recording under
control conditions and at about 5 min (steady state) after perfusion with ET-1. ET-1
induced an initial transient negative inotropic effect followed by an increase in cell
shortening in both genotypes. (B) Mean values of % cell shortening under controls
conditions and in the presence of ET-1 (steady state). ⁎Pb0.05 vs. control.
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Left ventricular (LV) myocytes were isolated using a standard
enzymatic dispersion technique as described elsewhere [16]. Brieﬂy,
the heart was initially perfused for 3 min with a nominally Ca2+-free
solution (in mM; NaCl 130, KCl 5.4, MgCl2 3.5, glucose 10, Hepes 5,
Na2HPO4 0.4, taurine 20 at a pH of 7.4), followed by a further 9 min
with the same solution with enzymes added (collagenase, 1 mg/ml,
Worthington Biochemical Co., protease, 0.133 mg/ml, Sigma Aldrich;
1.65 mg/ml BSA; Ca2+ 0.05 mM). The LV free wall was isolated and
placed in a separate ﬂask containing fresh collagenase-only solution.
Myocytes were harvested following further ﬁve and ten minute
digestion periods, washed twice and re-suspended in storage solution
(in mM; NaCl 120, KCl 5.4, MgSO4 5, CaCl2 0.2, Na-pyruvate 5, glucose
20, taurine 20, Hepes 10, pH 7.4, NaOH). The myocyte suspension was
stored at room temperature and cells were used within 8 h of
isolation.
2.3. Measurement of LV myocyte contraction
Isolated LV myocytes were superfused with a solution containing
(in mM) NaCl 140, KCl 5.4, MgCl2 1.2, HEPES 5, Glucose 10, CaCl2 1.4
at a pH of 7.4. Cell length was measured in LV myocytes ﬁeld
stimulated at 3 Hz by using a video-edge detection system (IonOptix
Corp). Cell shortening relative to diastolic cell length (% cell
shortening) was compared in LV myocytes from nNOS−/− mice
and their wild type littermates. Measurements from at least 10
steady state contractions were averaged for each cell for each stage
of the experimental protocols. All experiments were carried out at
35±1.5 °C.2.4. Measurement of superoxide production in LV myocytes
Superoxide production was measured by using lucigenin (5 μM)-
enhanced chemiluminescence in LV myocyte lysates from nNOS−/−
mice and their wild type littermates using a single vial luminometer
(Berthold FB12) modiﬁed to maintain the sample temperature at
37 °C, (as described and validated previously, [37]). Brieﬂy, aliquots of
isolated myocytes, which had been incubated at 37 °C in the storage
solution with or without ET-1 (10 nM), were homogenized by a
freezing–thawing method and transferred into scintillation vials
containing 800 μl Krebs-Hepes buffer (in mmol/l: NaCl 118, HEPES
10, NaHCO3 25, Glucose 5.6, KCl 4.7, KH2PO4 1.2, MgSO4 1.1, CaCl2 1.5 at
pH 7.4 after 60 min aeration with 95%O2 and 5%CO2) and 5 μM
lucigenin. After 1 min of acclimatisation, the chemiluminescence was
measured for a further 10min. The level of chemiluminescence during
the ﬁnal 1.5 min was determined after subtraction of the background
chemiluminescence of the lucigenin-containing buffer.
2.5. Chemicals
Endothelin-1 (ET-1, 10 nM, Merck Biosciences) was used to
stimulate NADPH oxidase activity. Membrane permeable amide (14-
22, PKI, 2 μM, Merck Biosciences) was used to inhibit the activity of
PKA. Chelerythrine (1 μM, Sigma) was used to inhibit the activity of
PKC. Apocynin (100 μM, Sigma) was used to inhibit NADPH oxidase
activity.
2.6. Statistics
Data are expressed as mean±s.e.m. and n indicates the number of
LV myocytes used. For all comparisons, cells were obtained from a
minimum of two hearts per genotype per protocol. Data were
analyzed using ANOVA (Microsoft Excel). A value of Pb0.05 was
considered to be statistically signiﬁcant.
3. Results and discussion
3.1. Role of NO and ROS downstream signaling in regulating myocardial
contraction and stretch responses
3.1.1. Role of nNOS-derived NO
Although eNOS-derived NO has been implicated in both the rapid
and slow inotropic response to stretch [8,9], this concept has been
challenged by more recent reports that failed to observe an effect of
non-isoform speciﬁc NOS inhibition on stretch-induced inotropy in
cardiac tissue or myocytes [6,12]. Whether nNOS-derived NO plays a
role in mechanotransduction and myocardial signaling downstream
of stretch and ET-1 receptor stimulation has not yet been
investigated. We compared the inotropic response to ET-1 (10 nM)
in LV myocytes isolated from nNOS−/− mice and their wild type
littermates (nNOS+/+).
As shown in Fig. 2A, ET-1 affected ﬁeld stimulated cell shortening
(3 Hz, 35 °C, as described in [21]) in nNOS+/+ LV myocytes in a time-
dependent manner. A small negative inotropic effect (at about 1 min
after the perfusion of ET-1) preceded an increase in cell shortening in
most of the cells studied. The positive inotropic effect of ET-1 reached
a plateau at 5–10 min. These results are in agreement with previous
evidence indicating that ET-1 exerts a biphasic inotropic response in
guinea-pig or cat cardiac myocytes [38,39]. On average, % cell
shortening in LV myocytes from nNOS+/+ mice increased from
5.3±0.3% to7.1±0.4% 5min after perfusionwith a solution containing
ET-1 (Pb0.001, n=24).
The inotropic effect of ET-1 did not differ in LVmyocytes frommice
with selective deletion of the nNOS gene (Fig. 2B); after 5 min the
absolute increase in cell shortening induced by ET-1 was 1.8±0.4 μm
in nNOS+/+ (n=24) and 2.2±0.4 μm in nNOS−/− (n=15, P=0.4
Fig. 3. Effect of NADPH oxidase inhibitionwith apocynin on basal and ET-1 inotropy. (A)
Continuous recordings of ﬁeld stimulated (3 Hz) myocyte shortening in the presence of
apocynin (100 μM) and ET-1. ET-1 (10 nM) failed to induce a positive inotropic effect in
both nNOS+/+ and nNOS−/− LV myocytes pre-incubated with apocynin. NADPH
oxidase inhibition caused a signiﬁcant reduction in cell shortening in nNOS−/− mice
but not in their wild type littermates. (B) In the presence of apocynin, mean cell
shortening did not differ between genotypes and between control and ET-1.
Fig. 4. Measurement of superoxide production using lucigenin (5 μM)-enhanced
chemiluminescence in LV myocyte homogenates from nNOS+/+ and nNOS−/− mice.
ET-1 (10 nM) was pre-incubated for 5 min at 37 °C and LV myocytes were homogenized
using a freeze–thaw method (repeated 6 times). (A) Superoxide release did not differ
between control and ET-1 treated nNOS+/+ myocytes. Application of apocynin
(100 μM) did not affect superoxide release suggesting that NADPH oxidase activity is
undetectable under basal conditions. (B) Basal superoxide release was greater in
nNOS−/− than in nNOS+/+ myocytes. Apocynin signiﬁcantly reduced superoxide
production suggesting that NADPH oxidase activity is enhanced in the absence of nNOS.
ET-1 also failed to increase superoxide production in nNOS−/− myocytes. ⁎Pb0.05 vs.
control.
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nNOS−/− myocytes was greater than in their wild type littermates
(P=0.01). These data suggest that nNOS-derived NO is unlikely to
play an important role in the inotropic response to ET-1 in murine LV
myocytes.
It is important to note that the role of nNOS in stretch-induced
slow force response is still an open question. The release of Ang II and
ET-1 may have been shown to be entirely responsible for stretch-
increased force in some studies, e.g. [4]; but others failed to detect the
involvement of these neurohormones in the slow response to stretch
[6,40]. In these studies, the slow force response to stretch of the
human ventricular myocardium was unaffected by the inhibition of
Ang II and ET-1 receptors; whereas it responded to the activation of
myosin light chain kinase (MLCK, [40]), as discussed below). Whether
or not nNOS is involved in MLCK signaling under stretch and regulates
force generation warrants further investigation.
In contrast to our ﬁndings, Nishimaru et al. have recently shown
that ET-1 induces a negative inotropic effect in murine LV myocytes
[41]. The reason for this discrepancy is not clear and may be due to
differences in experimental conditions (e.g. notably in ﬁeld stimula-
tion frequency, 0.5 Hz in Nishimaru et al. vs. 3 Hz in our study).
Stimulation of NHE activity by ET-1 may shift the inotropic response
from negative to positive, as shown in studies where NHE inhibition
was associated with a negative inotropic response to ET-1 [38,42].
Differences in NHE expression or activation between mice strains may
therefore contribute to the variability in the ET-1 inotropic response.
3.1.2. Role of NADPH oxidase activity and ROS
To investigate the involvement of NADPH oxidase in the inotropic
response to ET-1, LV myocytes were incubated for 30 min in perfusion
solution in the presence or absence 100 μM apocynin, a potent NADPH
oxidase inhibitor. Fig. 3 shows that the positive inotropic effect of ET-1
(10 nM) is totally prevented by pre-incubation with apocynin both innNOS−/− and nNOS+/+myocytes, suggesting that myocardial NADPH
oxidases are instrumental in mediating the inotropic response to ET-1
in the murine LV myocardium, irrespective of nNOS.
Apocynin signiﬁcantly reduced basal cell shortening in LV
myocytes from nNOS−/− mice but not in their wild type littermates
(from 6.7±0.4% under control conditions to 4.8±1.6% in the presence
of apocynin in nNOS−/−, Pb0.01, n=15 and 10 and from 5.3±0.3% to
5.6±0.5% in nNOS+/+, P=0.6, n=24 and 12, respectively).
These data suggest that stimulation of myocardial superoxide
production [20,36,43] by NADPH oxidases may play an important role
inmediating the increase in basal inotropy observed in the presence of
nNOS gene deletion or inhibition.
Next, we compared superoxide release using lucigenin-enhanced
chemiluminescence in LV myocytes from nNOS+/+ and nNOS−/−
mice that had been pre-incubated in the presence or absence ET-1 and
then lysed. Apocynin (100 μM, 10 min) was then applied to the LV
myocyte lysates to assess the contribution of NADPH oxidases.
Fig. 4A shows that basal superoxide productionwas not affected by
apocynin application in LV myocyte lysates from nNOS+/+ mice,
suggesting that under basal conditions, NADPH oxidase activity in
wild type LV myocytes must be very low. Surprisingly, ET-1 did not
cause a signiﬁcant increase in superoxide production in these cells
(Fig. 4A).
Superoxide production has previously been shown to be
increased in intact LV myocytes [43], LV homogenates [20] or tissue
chunks from nNOS−/− mice [36]. In agreement with these data, we
found a signiﬁcant increase in basal superoxide production in LV
Fig. 5. Effect of PKC or PKA inhibition on the ET-1 positive inotropic response. A and B.
PKC inhibition with chelerythrine (CLT, 1 μM) did not affect the inotropic effect of ET-1
in either group. In contrast, PKA inhibition with PKI (2 μM) signiﬁcantly reduced the
effect of ET-1 in nNOS+/+ and nNOS−/− myocytes. Under basal conditions, cell
shortening before and after CLT was 5.4±0.4 and 5.3±0.4 in nNOS+/+, n=11;
6.8±0.7 and 6.6±0.6 in nNOS−/−, n=7. Similarly, before and after PKI was 4.6±0.3
and 3.5±0.3 in nNOS+/+, n=12; 6.1±0.6 and 4.4±0.5 in nNOS−/−, n=16.
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oxidase activity caused a signiﬁcant reduction in superoxide
production in the nNOS−/− myocardium (Fig. 4B) so that, in the
presence of apocynin, there was no difference in myocardial
superoxide release between nNOS+/+ and nNOS−/− mice. Pre-
incubation of nNOS−/− LV myocytes with ET-1 resulted in a trend
towards an increase in superoxide production that did not reach
statistical signiﬁcance (Fig. 4B). As shown under basal conditions,
apocynin greatly reduced superoxide release in nNOS−/− myocytes
in the presence of ET-1 (Fig. 4B).
Taken together, these ﬁndings suggest that nNOS gene deletion
increases the activity of myocardial NADPH oxidases and that the
resulting increase in superoxide production may contribute to the
greater cell shortening and LV inotropy in nNOS−/− mice.
Although inhibition of NADPH oxidases abolished the positive
inotropic effect of ET-1 in both genotypes, we have been unable to
detect a signiﬁcant increase in superoxide production in myocyte
lysates following incubation with ET-1. This unexpected ﬁnding may
reﬂect the inability of our technique to detect localized superoxide
release in subcellular microdomains.
3.1.3. The downstream targets of NADPH oxidase and ROS — Ca2+
handling proteins
The emerging role of NADPH oxidases in the myocardial
response to stretch has opened the possibility that ROS formation
may be routinely involved in the regulation of myocardial inotropy
under physiological conditions. Indeed, several Ca2+ handling
proteins in the mammalian myocardium are redox sensitive (i.e.,
the L-type Ca2+ channel, RyR and the NCX [44]). Exogenous ROS
can either increase or decrease the amplitude of L-type Ca2+
currents [44,45] and ET-1 has recently been shown to activate L-
type Ca2+ channels through a mechanism that involves stimulation
of NADPH oxidase activity and superoxide production in cardiac
myocytes [46]. Similarly, exogenous ROS substantially enhanced
NCX-mediated Ca2+ ﬂuxes in cardiac sarcolemmal vesicles or in
isolated cardiac myocytes [47,48]. ET-1 and PKC – both of which are
known to stimulate NADPH oxidase activity [46,49] – also increase
the NCX current in guinea-pig ventricular myocytes [50]. Finally, the
increase in NCX activity and Ca2+ transient amplitude elicited by
Ang II or ET-1 can be prevented by inhibiting NADPH oxidase
activity [4,51,52].
Stretch-activated channels (SAC) are permeable to both Ca2+ and
Na+ ions. Activation of SAC bymechanical stretch depolarizes diastolic
membrane potential, prolongs action potential duration (APD) and
triggers spontaneous action potentials [53]. The signaling pathways
involved in the regulation of SAC by stretch are largely unknown.
Phorbol 12,13-dibutyrate (PDBu), which is known to mimic diacyl-
glycerol (DAG) and activate PKC, dose-dependently increased SAC in
rat atrial myocytes. A structural analogue of DAG that does not activate
PKC, 4α-phorbol, failed to show any effect on SAC. PKC inhibitor,
chelerythrine (1 μM), eliminated the effect of PDBu on SAC
(unpublished data). Application of oxidants activates non-selective
cation channels, increase intracellular Ca2+ and depolarizes the
membrane potential in non cardiac cells such as insulin-secreting
cell line [54,55].
3.2. Myocardial signaling involved in stretch-induced inotropic responses
3.2.1. Role of protein kinase C and protein kinase D
Activation of PKC-dependent signaling in cardiac myocytes
exposed to stretch or ET-1 [56] suggests that this kinase may be
involved in mediating the positive inotropic response to ET-1. In cat
papillary muscles or guinea-pig ventricular myocytes, PKC inhibition
reversed the positive inotropic effects of ET-1 [38,57]. However, in our
hands application of the PKC inhibitor, chelerythrine (CLT, 1 μM), did
not affect basal cell shortening or prevent the positive inotropic effectof ET-1 in either nNOS+/+ or nNOS−/− LVmyocytes (Fig. 5A and B). In
the presence of CLT, ET-1 increased cell shortening from 5.3±0.4% to
6.3±0.6% in nNOS+/+ myocytes (Pb0.01, n=11) and from 6.6±0.6
to 8.4±0.7% in nNOS−/− myocytes (Pb0.01, n=7). These data
suggest that PKC is not involved in the positive inotropic effect of ET-1
in murine LV myocytes.
Protein kinase D (PKD) is also activated by ET-1 in cardiac
myocytes mostly via a PKC-dependent mechanism [58]. PKD appears
to target the Ser22 and Ser23 phosphorylation sites in cardiac troponin
I (which are also phosphorylated by PKA) and to reduce the
myoﬁlament Ca2+ sensitivity [59]. This effect would be expected to
result in a reduction in myocardial inotropy; however, the relevance of
PKD in the fast and slow inotropic response to stretch has yet to be
investigated.
3.2.2. Role of protein kinase A
Cyclic AMP-dependent signaling may play an important role in
mediating the Anrep effect. For instance, Calaghan et al. [60] showed
that the myocardial cAMP content was signiﬁcantly increased in ferret
papillary muscles that developed a slow positive inotropic response to
stretch but not in those where stretch could not elicit an increase in
contraction. Similarly, increased myocardial cAMP has been observed
following stretch of isolated frog ventricles [61], in LV pressure-
overloaded Langendorff-perfused rat hearts [62], and in the canine
heart in situ following LV stretch [63]. In view of these ﬁndings, we
investigated whether PKA-dependent signaling was required for the
development of a positive inotropic response to ET-1 in LV myocytes
from nNOS+/+ and nNOS−/− mice.
As shown in Fig. 5A and B, inhibition of PKA by PKI (2 μM)
signiﬁcantly reduced the positive inotropic effect of ET-1 in both
nNOS+/+ and nNOS−/− LV myocytes. Both basal and ET-1-stimulated
cell shortening was not different between nNOS−/− and nNOS+/+
myocytes in the presence of PKI. These data suggest that PKAmay play
an important role in mediating ET-1 and stretch-mediated inotropic
responses in the murine LV myocardium.
PKA activation by ET-1may involve local production of ROS from
NADPH oxidase. Indeed Brennan et al. have shown that hydrogen
peroxide can directly activate type I PKA by inducing the formation of
an interprotein disulﬁde bond between its two regulatory subunits
[64]. This process leads to an increase in cell shortening via activation
and subcellular translocation of PKA, in the absence of adrenergic
receptor stimulation.
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oxidase may lead to increased myocardial inotropy through
stimulation and subcellular targeting of PKA signaling by ROS.
3.2.3. Myosin light chain kinase
Kockskämper et al. have recently suggested that MLCK may be
involved in the positive inotropic effect of stretch in the human
atrial and ventricular myocardium. In this work, stretch led to a
signiﬁcant increase in MLCK-dependent myosin light chain 2
(MLC2) phosphorylation and inhibition of MLCK blunted the
stretch-induced positive inotropic effect [40]. These results are
consistent with in vivo investigations showing that exercise-induced
elevations in LV preload are associated with increased MLC2
phosphorylation [65].
4. Conclusion
Mechanical stretch plays an important role in the modulation of
myocardial inotropy and growth responses both in health and in
disease states. Whereas mechanical stimulation and increased LV
preload have been shown to stimulate NO release from the vascular
endothelium [7], which – in turn – facilitates the Frank–Starling
response [9], the role of myocardial constitutive NO production in
mediating either the rapid or the slow inotropic response to stretch
remains controversial. It is generally accepted that the myocardial
release of Ang II and ET-1 in response to stretch is instrumental in
mediating the slow inotropic response or Anrep effect. In agreement
with these ﬁndings, recent evidence suggests that stimulation of
NADPH oxidases (a known target of Ang II and ET-1) and ROS
formation may be of critical importance in mediating the Anrep
effect. Our ﬁndings indicate that the positive inotropic effect of ET-1
requires intact NADPH oxidase activity and PKA signaling. The latter
may be directly activated by ROS formation [64], opening the
possibility that the NO-redox state of the myocardium may directly
affect protein phosphorylation and the inotropic state, independent
of adrenergic receptor stimulation.
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